Impaired phonological short-term memory is a core feature of the logopenic variant of primary progressive aphasia (lvPPA), but it is not clear whether a core phonological processing deficit is also present. We asked three questions: (i) beyond short-term memory impairment, do people with lvPPA have an impairment within phonology itself?; (ii) is their performance in working memory and confrontation naming reflective of this phonological impairment and/or other key contributing deficits (e.g., semantic)?; and (iii) is their repetition performance related to structural and functional differences in key language-dominant regions? We compared non- word and word repetition and short-term memory performance in patients with typical, amnestic Alzheimer’s disease (tAD, n = 9), lvPPA per consensus criteria (n = 10), and others who previously satisfied definitions of lvPPA but had progressed with multi-domain cognitive impairments (lvPPA+, n = 8). Bayesian analyses revealed no group differences in phonological tasks of word and non-word repetition. There was, however, a very strong group effect on multi-syllabic word/phrase repetition. We found very strong evidence for an effect of self- reported hearing loss on both word and non-word repetition, but not multi-syllabic word/phrase repetition. A comparison of phonological (as indexed by non-word repetition) versus working memory (as measured by multisyllabic word repetition and digit span) and confrontation naming tasks produced either no evidence or evidence for no correlation. Confrontation naming correlated positively with multisyllabic word/phrase repetition and semantic assessments across the whole group. Beyond the expected grey matter reductions in patients relative to controls in the left posterior superior temporal gyrus, anterior temporal lobe, and inferior temporal gyrus, we found no evidence for the associations between non-word repetition and functional connectivity between all regions of interest in the whole group. When excluding controls, the only anecdotal evidence that was corroborated by frequentist multiple regression was for an association between non-word repetition and functional connectivity between dorsal premotor and posterior superior temporal gyrus after controlling for the grey matter volumes in these regions. We have shown that deficits in “pure” phonological tasks, namely single word and non-word repetition, are (i) not dependent on working memory and (ii) greater in patients with a self-reported hearing loss across all groups with lvPPA or tAD. Our results suggest that instead of having a core phonological impairment, lvPPA patients have a working memory/buffering impairment that adversely affects their performance on length-dependent working memory tasks.

The authors have declared no competing interest.

This work and the corresponding author (SKH) were supported and funded by the Bill & Melinda Gates Foundation, Seattle, WA, and Gates Cambridge Trust (Grant Number: OPP1144). This study was supported by the Cambridge Centre for Parkinson-Plus; the Medical Research Council (MC_UU_00030/14; MR/P01271X/1; MR/T033371/1); the Wellcome Trust (220258); the National Institute for Health and Care Research Cambridge Clinical Research Facility and the National Institute for Health and Care Research Cambridge Biomedical Research Centre (BRC-1215-20014; NIHR203312); an intramural award (MC_UU_00005/18) to the MRC Cognition and Brain Sciences Unit; Alzheimer's Society (grant number 602). For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All participants gave written informed consent in accordance with the Declaration of Helsinki, with patients being supported by family when necessary. Study ethics approval was obtained from the MRC Cognition and Brain Sciences Unit at the University of Cambridge (REC#01/8/94).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes